Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ, ÖZTÜRK; BABACAN, TANER; KERTMEN, NEYRAN; Sarici, Furkan; Cenoli, Alma; AKIN, SERKAN; Karakas, Yusuf; KILIÇKAP, SAADETTİN; Ozisik, Yavuz; SEVER, ALİ; AKSOY, SERCAN; Altundag, Kadri

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

Atıf İçin Kopyala

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., ...Daha Fazla

JOURNAL OF BUON, cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 2
Basım Tarihi: 2016
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.375-381
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: Eribulin is a non-taxane microtubule inhibitor, which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of eribulin monotherapy in heavily pretreated MBC patients.